CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 61 filers reported holding CHEMOCENTRYX INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $36,835,000 | +24957.8% | 713,026 | +6309.2% | 0.11% | +11200.0% |
| Q2 2018 | $147,000 | -93.8% | 11,125 | -98.8% | 0.00% | -92.9% |
| Q1 2016 | $2,378,000 | -82.0% | 955,134 | -41.5% | 0.01% | -84.8% |
| Q4 2015 | $13,214,000 | -6.3% | 1,631,326 | -30.0% | 0.09% | -11.5% |
| Q3 2015 | $14,104,000 | -23.7% | 2,331,200 | +3.8% | 0.10% | -8.0% |
| Q2 2015 | $18,479,000 | +31.1% | 2,245,275 | +20.2% | 0.11% | -0.9% |
| Q1 2015 | $14,100,000 | +14.0% | 1,867,597 | +3.2% | 0.11% | 0.0% |
| Q4 2014 | $12,365,000 | -0.6% | 1,810,456 | -34.5% | 0.11% | +18.8% |
| Q3 2014 | $12,439,000 | -22.8% | 2,764,227 | +0.4% | 0.10% | -47.3% |
| Q2 2014 | $16,109,000 | +6.1% | 2,753,650 | +20.2% | 0.18% | +5.2% |
| Q1 2014 | $15,185,000 | +126.4% | 2,290,421 | +97.7% | 0.17% | +98.9% |
| Q4 2013 | $6,708,000 | +150.1% | 1,158,613 | +140.2% | 0.09% | +141.7% |
| Q3 2013 | $2,682,000 | – | 482,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,796,516 | $45,142,000 | 7.90% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $5,790,000 | 4.09% |
| Belmont Global Advisors, Inc. | 175,000 | $1,013,000 | 0.82% |
| Broadfin Capital, LLC | 1,033,668 | $5,985,000 | 0.79% |
| WASATCH ADVISORS LP | 2,650,551 | $15,347,000 | 0.15% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,158,613 | $6,708,000 | 0.09% |
| Artal Group S.A. | 275,000 | $1,592,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 41,355 | $239,000 | 0.05% |
| A.R.T. Advisors, LLC | 33,501 | $193,000 | 0.01% |
| BANQUE PICTET & CIE SA | 50,932 | $295,000 | 0.01% |